secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0000950170-23-016054
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health appoints interim CFO Kimberly Bambach, strategic advisor Christina Valauri; CFO Veronica Cai resigns
--------------------------------------------------------------------------------

- CFO Veronica Cai resigned effective April 28, 2023; receives $125K lump sum upon signing release.
- Kimberly Bambach appointed interim CFO, paid $200/hour as non-employee consultant.
- Christina Valauri engaged as strategic advisor to board; former healthcare analyst at Cantor Fitzgerald.
- Cai stated resignation not due to any disagreement with company's operations or policies.
- Bambach brings 30+ years financial leadership; previously CFO of Jushi Holdings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/tivc-20230428.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-016054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer